Biotech Stocks

Novartis telegraphs 130 job cuts amid biologics rethink in Switzerland

FiercePharma 2h ago Restructuring

Novartis could cut about 130 jobs in Switzerland as it rethinks its biologics technical development and production footprint in Basel.

Discussion

Sign in to join the discussion. Comments loading…